(2020). Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.
Chicago Style (17th ed.) CitationGood or Bad: Application of RAAS Inhibitors in COVID-19 Patients with Cardiovascular Comorbidities. 2020.
MLA (8th ed.) CitationGood or Bad: Application of RAAS Inhibitors in COVID-19 Patients with Cardiovascular Comorbidities. 2020.
Warning: These citations may not always be 100% accurate.